Mont M A, Payman R K, Laporte D M, Petri M, Jones L C, Hungerford D S
Department of Orthopaedic Surgery, the Johns Hopkins University Medical Institutions, Baltimore, Maryland, USA.
J Rheumatol. 2000 Jul;27(7):1766-73.
To define the epidemiology, clinical and radiographic presentation, treatment, and prognosis of atraumatic osteonecrosis of the humeral head.
Of the 1,056 patients managed for osteonecrosis of any joint between July 1, 1974, and December 1, 1996, 127 shoulders in 73 patients were treated for atraumatic osteonecrosis of the proximal humerus. Clinical and radiographic characterization of this patient cohort was performed.
At presentation, there were 47 women and 26 men with a mean age of 41 years (range 20-60). Numerous associated factors were noted: alcohol use (38%), moderate smoking (30%), asthma (8%), and nephrosis (3%). A corticosteroid association was noted in 60 patients (82%) and 42 of the patients (58%) had an immunocompromising disease. The severity of humeral head osteonecrosis did not correlate with dose or duration of corticosteroid therapy. According to the modified Ficat and Arlet radiographic staging system, there were 20 shoulders with Stage I disease, 55 shoulders with stage II disease, and 52 shoulders with Stage ITI or IV disease. Seventy-four of the shoulders treated with core decompression (78%) had good to excellent clinical outcomes at a mean followup of 6 years (range 2-21). Fourteen of the 16 patients (88%) treated with hemiarthroplasty or total shoulder arthroplasty were clinically successful at a mean followup 4 years (range 2-11).
We observed a low incidence of humeral head involvement in the osteonecrosis patient cohort (7% of all osteonecrosis patients), and a high incidence of corticosteroid use (82%). hip involvement (81%), and bilateral disease (74%). Osteonecrosis of the humeral head should be suspected in patients presenting with shoulder pain and a history of osteonecrosis in other joints. Hip screening for osteonecrosis is advocated in patients with shoulder involvement. Early detection of shoulder osteonecrosis may permit a more conservative, joint-sparing approach as an alternative to surgical management.
明确非创伤性肱骨头缺血性坏死的流行病学、临床及影像学表现、治疗方法及预后。
在1974年7月1日至1996年12月1日期间接受任何关节缺血性坏死治疗的1056例患者中,73例患者的127个肩部接受了近端肱骨非创伤性缺血性坏死的治疗。对该患者队列进行了临床和影像学特征分析。
就诊时,有47名女性和26名男性,平均年龄41岁(范围20 - 60岁)。发现众多相关因素:饮酒(38%)、中度吸烟(30%)、哮喘(8%)和肾病(3%)。60例患者(82%)有皮质类固醇使用史,42例患者(58%)患有免疫功能低下疾病。肱骨头缺血性坏死的严重程度与皮质类固醇治疗的剂量或疗程无关。根据改良的菲卡特和阿莱特影像学分期系统,有20个肩部为I期疾病,55个肩部为II期疾病,52个肩部为III期或IV期疾病。74个接受髓芯减压治疗的肩部(78%)在平均6年(范围2 - 21年)的随访中临床疗效为良好至优秀。16例接受半关节置换术或全肩关节置换术的患者中有14例(88%)在平均4年(范围2 - 11年)的随访中临床治疗成功。
我们观察到在缺血性坏死患者队列中肱骨头受累的发生率较低(占所有缺血性坏死患者的7%),而皮质类固醇使用、髋部受累(81%)和双侧疾病(74%)的发生率较高。对于出现肩部疼痛且有其他关节缺血性坏死病史的患者,应怀疑肱骨头缺血性坏死。对于肩部受累的患者,提倡进行髋部缺血性坏死筛查。早期发现肩部缺血性坏死可能允许采用更保守的、保留关节的方法作为手术治疗的替代方案。